Flagship Ventures plans to invest £100 million to build an AI-driven pharmaceutical company in the UK. The article mainly explains the platform nature of Global Banking & Finance Review® and its content disclaimer, and does not provide details on the investment target, funding arrangements beyond the stated amount, or project progress.
Source:globalbankingandfinance.com · Read Original
Leave a Reply